HopeStage
Back to all studies
RecruitingNCT04123314

Study of psilocybin for depression with mild cognitive impairment or early Alzheimer’s disease

About this titleRead the official source — NCT04123314
Medication studyAges 18–85United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 85 years.

What will I do during this study?

You take part in an eight-week open-label study with weekly psychological support and two psilocybin sessions, in weeks four and six. The study includes follow-up assessments for up to six months after the second session.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Number of visits
2 psilocybin sessions are planned in weeks 4 and 6, with weekly psychological support during an 8-week study.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 24, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 85 Years
Official registry ID
NCT04123314
Official title
Show the full official title

Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease

Recruitment & locations

Currently recruiting

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 18 years to 85 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies